Chronic Obstructive Pulmonary Disease (COPD) Research – Clinical Leader


Clinical Leader

Chronic Obstructive Pulmonary Disease (COPD) Research
Clinical Leader
Respiratory studies—particularly those for COPD—pose extraordinary logistical and clinical challenges for sponsors. inVentiv Health, having extensive experience in conducting COPD trials, has developed unique ways to overcome these challenges.

How Resveratrol, Feature of Red Wine, Works to Fight Bacteria-linked Lung Inflammation Detailed in Study – COPD News Today


COPD News Today

How Resveratrol, Feature of Red Wine, Works to Fight Bacteria-linked Lung Inflammation Detailed in Study
COPD News Today
“It has been shown that resveratrol can suppress inflammation, but how it regulates inflammation still remains largely unknown. We found that resveratrol suppresses a major bacterial pathogen causing otitis media and COPD by upregulating or increasing ...
Component of red wine, grapes can help to reduce inflammation, study findsScience Daily
Red Wine Component May Combat Lung DiseasesNewsmax

all 3 news articles »

Advanced COPD Therapeutics In Major Developed Markets Overview To 2021 – Emergence Of Addition-In-Class And … – Medgadget (blog)


Advanced COPD Therapeutics In Major Developed Markets Overview To 2021 – Emergence Of Addition-In-Class And ...
Medgadget (blog)
MrrBiz374 The report “COPD Therapeutics In Major Developed Markets To 2021 – Emergence Of Addition-In-Class And First-In-Class Products Offsets Sales Erosion Of Leading Brands”, has been prepared based on an in-depth market analysis with inputs ...

Novel trial design establishes clinical effectiveness of fluticasone furoate-vilanter in COPD: The Salford Lung Study – 2 Minute Medicine


Novel trial design establishes clinical effectiveness of fluticasone furoate-vilanter in COPD: The Salford Lung Study
2 Minute Medicine
1. A once-daily treatment of combined fluticasone furoate-vilanterol was associated with a significantly lower rate of exacerbations than usual care in patients with chronic obstructive pulmonary disease (COPD), without an increased risk of serious ...